- JP-listed companies
- HOKUYAKU TAKEYAMA Holdings,Inc.
- Income statement
HOKUYAKU TAKEYAMA Holdings,Inc. (3055) Income statement
Market cap
P/E ratio
Hokuyaku Takeyama Holdings distributes pharmaceuticals and medical devices to hospitals and pharmacies across Japan, while also operating dispensing pharmacies and care facilities.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 202,402 | 205,215 | 214,465 | 212,106 | 225,146 | 228,713 | 227,788 | 235,153 | 243,102 | 239,494 | 248,369 | 261,979 | 275,364 | 289,534 |
| Revenue growth (%) | - | |||||||||||||
| Cost of revenue | - | - | - | 196,233 | 207,808 | 211,356 | 209,865 | 216,942 | 223,750 | 221,588 | 229,574 | 242,020 | 254,606 | 267,938 |
| Gross profit | - | - | - | 15,872 | 17,337 | 17,356 | 17,922 | 18,211 | 19,351 | 17,906 | 18,795 | 19,959 | 20,758 | 21,595 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating margin (%) | - | - | - | |||||||||||
| Operating expenses | - | - | - | 14,145 | 14,938 | 15,272 | 15,424 | 15,752 | 16,377 | 16,460 | 16,663 | 17,330 | 17,930 | 18,668 |
| Operating income | - | - | - | 1,727 | 2,399 | 2,084 | 2,498 | 2,458 | 2,973 | 1,445 | 2,131 | 2,628 | 2,827 | 2,927 |
| Income before tax | 2,575 | 2,729 | 3,068 | 2,556 | 3,256 | 3,005 | 3,502 | 3,452 | 4,121 | 2,691 | 3,413 | 3,887 | 3,533 | 3,637 |
| Pretax margin (%) | 1.3 | 1.3 | 1.4 | 1.2 | 1.4 | 1.3 | 1.5 | 1.5 | 1.7 | 1.1 | 1.4 | 1.5 | 1.3 | 1.3 |
| Provision for income taxes | - | - | - | 1,234 | 1,366 | 1,555 | 1,306 | 1,263 | 1,345 | 1,053 | 952 | 1,498 | 1,371 | 1,263 |
| Effective tax rate (%) | - | - | - | |||||||||||
| Net income | 581 | 582 | 573 | 1,192 | 1,810 | 988 | 2,160 | 2,102 | 2,046 | 1,494 | 2,806 | 2,731 | 2,177 | 2,473 |
| Net income margin (%) | ||||||||||||||
| Earnings per share | 46.66 | 61.24 | 65.8 | 47.57 | 73.08 | 40.04 | 89.14 | 88.96 | 86.81 | 64.01 | 123.44 | 123.41 | 100.2 | 116.44 |
| Dividend per share | - | - | - | - | - | - | - | - | 17 | 15 | 17 | 20 | 20 | 20 |
| EBITDA | - | - | - | |||||||||||
| EBITDA margin (%) | - | - | - |